or Try an Advanced Search...

    Technical Analysis for OCEA - Ocean Biomedical, Inc.

    Grade Last Price % Change Price Change
    F 0.69 -3.99% -0.03
    OCEA closed down 3.99 percent on Wednesday, November 20, 2024, on 48 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    Earnings due: Dec 4
    *** please verify all earnings dates ***
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical OCEA trend table...
    Date Alert Name Type % Chg
    180 Bearish Setup Bearish Swing Setup 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    New Downtrend Bearish -3.99%
    Lower Bollinger Band Walk Weakness -3.99%
    Outside Day Range Expansion -3.99%
    Wide Bands Range Expansion -3.99%
    Gapped Up Strength -3.99%
    Lower Bollinger Band Touch Weakness -3.99%
    Older End-of-Day Signals for OCEA ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day about 18 hours ago
    Down 5% about 18 hours ago
    Down 3% about 18 hours ago
    60 Minute Opening Range Breakdown about 20 hours ago
    Down 2 % about 20 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    OCEA Chart by TradingView
    Basic chart:

    Profile

    Ocean Biomedical, Inc. is a Providence, Rhode Island-based biopharma company with an innovative business model that accelerates the development and commercialization of scientifically compelling assets from research universities and medical centers. Ocean Biomedical deploys the funding and expertise to move new therapeutic candidates efficiently from the laboratory to the clinic, to the world. Ocean Biomedical is currently developing five promising discoveries that have the potential to achieve life-changing outcomes in lung cancer, brain cancer, pulmonary fibrosis, and the prevention and treatment of malaria. The Ocean Biomedical team is working on solving some of the world’s toughest problems, for the people who need it most.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Lung Cancer Pulmonary Fibrosis Malaria Brain Cancer Treatment Of Malaria

    Is OCEA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 22 Ocean Biomedical receives Nasdaq’s delisting letter
    Oct 22 Ocean Biomedical, Inc. Announces Receipt of Nasdaq Staff Determination Letter
    Oct 1 Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Publication of New Data Deepening Understanding of Novel Cancer Immunotherapy Treatment Approach Targeting CHI3L1 and its Ability to Inhibit Anti-tumor and Related Tissue Remodeling Responses
    Aug 27 Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Issued for PfGARP Malaria Antibodies Central to Company’s Malaria Treatment and Prevention Platforms
    Aug 23 Ocean Biomedical receives non-compliance notice from Nasdaq
    Jun 5 Ocean Biomedical (NASDAQ: OCEA) Congratulates Joint Venture Partner, Virion Therapeutics, on Positive Immunogenicity Results from Their Lead Checkpoint Modifier-Containing Immunotherapy, VRON-0200, for HBV Functional Cure, at EASL 2024
    May 30 Ocean Biomedical gets non-compliance notice from Nasdaq
    May 30 Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
    See more OCEA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 7.79
    52 Week Low 0.52
    Average Volume 51,924
    200-Day Moving Average 1.54
    50-Day Moving Average 0.90
    20-Day Moving Average 0.82
    10-Day Moving Average 0.74
    Average True Range 0.07
    RSI (14) 31.97
    ADX 25.63
    +DI 11.39
    -DI 22.48
    Chandelier Exit (Long, 3 ATRs) 0.83
    Chandelier Exit (Short, 3 ATRs) 0.85
    Upper Bollinger Bands 1.01
    Lower Bollinger Band 0.64
    Percent B (%b) 0.14
    BandWidth 45.01
    MACD Line -0.07
    MACD Signal Line -0.06
    MACD Histogram -0.0131
    Fundamentals Value
    Market Cap 23.52 Million
    Num Shares 34.1 Million
    EPS -2.55
    Price-to-Earnings (P/E) Ratio -0.27
    Price-to-Sales 0.00
    Price-to-Book 100.67
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.76
    Resistance 3 (R3) 0.77 0.75 0.75
    Resistance 2 (R2) 0.75 0.73 0.75 0.75
    Resistance 1 (R1) 0.72 0.72 0.71 0.71 0.74
    Pivot Point 0.70 0.70 0.70 0.70 0.70
    Support 1 (S1) 0.67 0.68 0.66 0.67 0.64
    Support 2 (S2) 0.65 0.67 0.65 0.63
    Support 3 (S3) 0.62 0.65 0.63
    Support 4 (S4) 0.62